NCT02674139

Brief Summary

The study aims to compare immediate post-placental (within 10 minutes of placenta delivery) intrauterine contraceptive device (Copper T 380A) insertion versus conventional placement at 6 weeks (often referred to as delayed or interval insertion) regarding the clinical outcomes (safety, efficacy, expulsion and continuation rates) for women undergoing caesarean section.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Feb 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

September 27, 2016

Status Verified

September 1, 2016

Enrollment Period

1.1 years

First QC Date

January 30, 2016

Last Update Submit

September 26, 2016

Conditions

Keywords

post placental-caesarean-IUD

Outcome Measures

Primary Outcomes (1)

  • Expulsion: Complete IUD expulsion will be verified clinically and by transvaginal ultrasound

    Complete IUD expulsion will be verified clinically and by transvaginal ultrasound. An IUD will be considered to be partially expelled if a distance greater than 10 mm is measured between the vertical arm of the IUD and the junction between the endometrium and the uterine cavity)

    6 months

Secondary Outcomes (6)

  • Uterine perforation (assessed by pelvic ultrasonography or X-ray)

    6 months

  • Pelvic pain (using the 0-10 Numeric Pain Rating Scale)

    6 months

  • Strings not visible (assessed by speculum examination)

    6 months

  • Pelvic infection: number of participants with Pelvic infection

    6 months

  • Psychological (satisfied or not) using questionnaire

    6 months

  • +1 more secondary outcomes

Study Arms (2)

IUD insertion 6 Weeks after delivery

ACTIVE COMPARATOR

Subjects randomized to interval placement will have their Copper T 380A IUD placed in the office at six weeks postpartum or later

Device: Copper T 380A IUD

Immediate Post-placental insertion

EXPERIMENTAL

Subjects randomized to receive the Copper T 380A IUD within 10 minutes of delivery of the placenta during caesarean section.

Device: Copper T 380A IUD

Interventions

intrauterine contraceptive device T-shaped loaded with cupper

Also known as: Pregna
IUD insertion 6 Weeks after deliveryImmediate Post-placental insertion

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18 - 45 years.
  • GA 36-40 weeks based upon the date of last normal menstruation, confirmed by ultrasonographic scan.
  • Desire to have intrauterine contraceptive device (Cu T) after counseling about different contraceptive options and consented to the study.

You may not qualify if:

  • Allergy to copper.
  • Ante- or intra-partum hemorrhage.
  • Hemorrhagic disorders.
  • Current or past history of pelvic inflammatory disease.
  • Women known to have pelvic TB.
  • Known to have ruptured membranes for more than 24 h prior to delivery.
  • History of chorioamnionitis.
  • Known uterine abnormalities e.g., Bicornuate/septate Uterus, uterine myoma.
  • Patients presented with febrile morbidity prior to the operation defined as temperature above 38'c.
  • Multiple pregnancies.
  • Placenta previa.
  • History of ectopic pregnancy.
  • Anemia (hemoglobin \<10 g/dl).
  • Cervical cancer or carcinoma in situ.
  • Diagnosis of active cervical infection for standard insertion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • sara AA mohamed, master

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer of Obstetrics and Gynecology Faculty of Medicine- Beni-sueif University

Study Record Dates

First Submitted

January 30, 2016

First Posted

February 4, 2016

Study Start

February 1, 2016

Primary Completion

March 1, 2017

Study Completion

June 1, 2017

Last Updated

September 27, 2016

Record last verified: 2016-09